Start the conversation
We've been promising you another "peanut allergy" stock.
Today we're keeping that promise.
And the timing couldn't be better.
Shares of Neogen Corp. (Nasdaq: NEOG) - a maker of allergen-detector kits - have soared nearly 40% since Radical Technology Profits Editor Michael Robinson told us about the company back in April 2014.
And Aimmune Therapeutics Inc. (Nasdaq: AIMT) - a Brisbane, Calif.-based biotech that's developed one of the first true treatments for food-allergy sufferers - last week proved itself to be every bit the hot initial public offering (IPO) that we've been expecting. In a rare move for us, we recommended the IPO and then watched as the company's shares rocketed 50% on their first day of trading.
We'd promised to circle back with one more recommendation.
And here it is...Full Story
This is premium content for Private Briefing subscribers only.